unanswered questions about the Redux (dexfenfluramine) and Pondimin (fenfluramine) withdrawal

    There are lots of unanswered questions about the Redux (dexfenfluramine) and Pondimin (fenfluramine) withdrawal.

    Preliminary tests suggest that 30% of patients on Redux or Pondimin might have damaged heart valves. There are also concerns about pulmonary hypertension and possible neurotoxicity.

    These problems might be due to too much serotonin.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote